Bunker Roy

Chris Anderson

Thomas Barnett

Jesse Sullivan & Todd Kuiken

Neal Gershenfeld

This is a video of a lecture from New York Biotechnology Association by Dr. Ron Nardi, formerly of Ferring Pharmaceutical. He covers his experiences with Target e*CRF®.

Target Health Inc. participates in the PopTech conferences each October and would like to share some experiences, through these videos.

Thomas Friedman


Lester Brown



Marcia McNutt

Solar Cells Get Cheaper By Copying Nature
Massey University, NZ

Massey University’s Nanomaterials Research Centre, has developed a solar cell technology that will enable New Zealanders to generate electricity from sunlight at one 10th of the cost of current silicon-based photo-electric solar cells.

Dr Wayne Campbell and researchers at the center, have developed a range of colored dyes for use in dye-sensitised solar cells.
The synthetic dyes are made from simple organic compounds closely related to those found in nature. The green dye is synthetic chlorophyll obtained from the light-harvesting pigment, that plants use for photosynthesis.

Other dyes being tested in the cells are based on haemoglobin, the compound that gives blood its color.

Unlike the silicon-based solar cells on the market now, the 10x10cm green demonstration cells, generate enough electricity to run a small fan in low-light conditions. This makes them ideal for cloudy climates. The dyes can also be incorporated into tinted windows that trap to generate electricity.

He says the green solar cells are more environmentally friendly than silicon-based cells as they are made from titanium dioxide – a plentiful, renewable and non-toxic white mineral obtained from New Zealand’s black sand. Titanium dioxide is already used in consumer products such as toothpaste, white paints and cosmetics.

“The refining of pure silicon, although a very abundant mineral, is energy-hungry and very expensive. And whereas silicon cells need direct sunlight to operate efficiently, these cells will work efficiently in low diffuse light conditions,” Dr Campbell says.

“The expected cost is one 10th of the price of a silicon-based solar panel, making them more attractive and accessible to home-owners.”

The Centre’s new director, Professor Ashton Partridge, says they now have the most efficient porphyrin dye in the world and aim to optimise and improve the cell construction and performance before developing the cells commercially.

“The next step is to take these dyes and incorporate them into roofing materials or wall panels. We have had many expressions of interest from New Zealand companies,” Professor Partridge says.

He says the ultimate aim of using nanotechnology to develop a better solar cell is to convert as much sunlight to electricity as possible.

“The energy that reaches earth from sunlight in one hour is more than that used by all human activities in one year”.

The solar cells are the product of more than 10 years research funded by the Foundation for Research, Science and Technology.

070405171830.jpg

Dr. Wayne Campbell. (Credit: Image courtesy of Massey University)

Target Health Inc. continues to donate $$ to Millennium Promise, an organization pledged to wipe out
global poverty by the year 2020. Millennium Promise was created by Jeffrey Sachs, head of The
Earth Institute at Columbia University and in partnership with the United Nations. Target Health urges readers to contribute, even $7 which will buy mosquito netting for one bed, and help to fight malaria in that way.

This is a video of a lecture from New York Biotechnology Association by Target Health’s own Dr. Jules Mitchel.

PillCam – Painless Diagnostic Device™

The Given® Diagnostic System is a first-line tool in the detection of abnormalities of the small 1) ___. To date over 400,000 patients worldwide have experienced the advantages of 2) ___ and effective PillCam Capsule Endoscopy. PillCam Capsule Endoscopy has already been utilized to diagnose diseases of the small intestine including Crohn’s Disease, Celiac disease and other malabsorption disorders, benign and malignant tumors of the small intestine, vascular disorders and medication related small bowel injury. Given Imaging Ltd. is developing a complete line of PillCam™ video capsules for detecting disorders of the 3) ___ tract. The company’s technology platform is the Given Diagnostic System, featuring the PillCam video capsule, a disposable, miniature video 4) ___ contained in a capsule, which is ingested by the patient. The PillCam SB capsule is a naturally ingested method for direct 5) ___ of the entire small intestine. It is currently marketed in the United States and in more than 60 other countries. The PillCam ESO video capsule, which provides visual examination of the esophagus, has been cleared for marketing by the 6) ___. Additional capsules for visualization of the stomach and colon are under development.

This is a video of a lecture from New York Biotechnology Association by Dr. Ben Levinson, formerly of InfaCare. He covers his experiences with Target e*CRF®.

← Previous PageNext Page →